Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This specialized medical gas mixture, consisting of carbon dioxide, oxygen, and argon, is utilized as a physiological probe in clinical research led by Cuneyt M. Alper. The mixture is specifically designed to study gas exchange kinetics across the middle ear mucosa in both healthy individuals and those with middle ear disease. By replacing nitrogen with argon—an inert gas with distinct diffusion properties—and precisely controlling the concentrations of O2 and CO2, researchers can measure the individual exchange rates of these gases between the middle ear cavity and the mucosal blood flow using mass spectrometry. This research is critical for understanding the mechanisms of middle ear pressure regulation and the pathophysiology of conditions such as otitis media and middle ear effusions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on carbon dioxide + oxygen + argon.